Uncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read More
Gene therapies: Million-dollar miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read More
The future of gene therapy
Recent research suggests that the number of gene therapies on the market is likely to increase to over 60 by 2030. As rapid advancements in the field continue, here is what plan sponsors can expect to...
Read More
Gene therapies 101
We answer our clients’ burning questions about gene therapies, including how they work, whether or not they’re safe, and if we’ll see more in the future.
Read More
Understanding gene modification and cellular therapies
Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology
Read More
What to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read More
How to have a data-driven discussion on gene and cellular therapies
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
Read More
Gene therapies, today and tomorrow
By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...
Read More
As more gene therapies come to market, payers need expanded options to protect their plans
Read More
Understanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read More